Chronic Lymphocytic Leukemia Moon Shot (CLL) update

submitted by: mdanderson

Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia. Michael Keating, M.D., professor in Leukemia at MD Anderson Cancer Center and one of the leaders in the CLL Moon Shot, discusses new advances in treating CLL, including alternatives to chemotherapy and using one’s own immune system to fight this disease.

First-year progress in MD Anderson’s Moon Shots Program

submitted by: mdanderson
The University of Texas MD Anderson Cancer Center in September 2012 announced its Moon Shots Program, an unprecedented effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. The program initially targets acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS); chronic lymphocytic leukemia (CLL); lung cancer; melanoma; prostate cancer; and triple-negative breast and high-grade serious ovarian cancers....

Melanoma in Immunosuppressed Patients

submitted by: WentzMR
Dr. Jerry Brewer, a Dermatologic Surgeon from the Department of Dermatology at Mayo Clinic in Rochester, MN, discusses his article appearing in the October 2012 issue of Mayo Clinic Proceedings, where he unmasks a previously unknown higher risk for melanoma in immunosuppressed and transplant patients. Available at: http://www.mayoclinicproceedings.org/article/S0025-6196(12)00730-6/fulltext Visit the Mayo Clinic Proceedings website: www.MayoClinicProceedings.org Find more videos:...

UT MD Anderson Cancer Center launches unprecedented Moon Shots Program to increase patient survival during the next decade

submitted by: mdanderson
Inspired by America’s drive a generation ago to put a man on the moon, MD Anderson’s Moon Shots Program is a highly-concentrated effort to rapidly and dramatically decrease suffering and death in several major cancers, including acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS); chronic lymphocytic leukemia (CLL); lung; melanoma; prostate and two cancers linked at the molecular level: triple-negative breast and ovarian. Focused teams are building on new technology and...

Increased Metastasis of Malignant Fibrous Histiocytoma in CLL and Non-Hodgkin Lymphoma.

submitted by: mcgheekkm

Dr. Jerry Brewer, a dermatologic surgeon in the Department of Dermatology at Mayo Clinic in Rochester, MN, discusses his article appearing in the August 2011 issue of Mayo Clinic Proceedings on the increased risk of metastasis in patients with CLL and Non-Hodgkin lymphoma who were previously diagnosed with malignant fibrous hystiocytoma. Available at: http://tinyurl.com/3h2xdsm